Ladislav Batalik1,2*
Katerina Filakova1Ivana Radkovcova1Filip Dosbaba1Petr Winnige1,2Daniela Vlazna1,3,4Katerina Batalikova1Marian Felsoci4,5Marios Stefanakis6
David Liska7
Jannis Papathanasiou8,9
Andrea Pokorna10
Andrea Janikova4,11
Sebastian Rutkowski12
Garyfallia Pepera13
- 1Department of Rehabilitation, University Hospital Brno, Brno, Czechia
- 2Department of Public Health, Faculty of Medicine, Masaryk University, Brno, Czechia
- 3Department of Neurology, University Hospital Brno, Brno, Czechia
- 4Faculty of Medicine, Masaryk University, Brno, Czechia
- 5Department of Internal Medicine and Cardiology, University Hospital Brno, Brno, Czechia
- 6Physiotherapy Department, University of West Attica, Athens, Greece
- 7Faculty of Arts, Department of Physical Education and Sports, Matej Bel University, Banská Bystrica, Slovakia
- 8Department of Medical Imaging, Allergology & Physiotherapy, Faculty of Dental Medicine, Medical University of Plovdiv, Plovdiv, Bulgaria
- 9Department of Kinesitherapy, Faculty of Public Health “Prof. Dr. Tzecomir Vodenicharov, Ph.D”, Medical University of Sofia, Sofia, Bulgaria
- 10Department of Health Sciences, Faculty of Medicine, Masaryk University, Brno, Czechia
- 11Department of Internal Medicine–Hematology and Oncology, University Hospital Brno, Brno, Czechia
- 12Faculty of Physical Education and Physiotherapy, Opole University of Technology, Opole, Poland
- 13Clinical Exercise Physiology and Rehabilitation Research Laboratory, Physiotherapy Department, School of Health Sciences, University of Thessaly, Lamia, Greece
The direct toxicity of cancer treatment threatens patients and survivors with an increased risk of cardiovascular disease or adverse functional changes with subsequent progression of cardiovascular complications. An accumulation of cardiovascular risk factors combined with an unhealthy lifestyle has recently become more common in cancer patients and survivors. It has been recommended to integrate a comprehensive cardiac rehabilitation model called cardio-oncology rehabilitation to mitigate cardiovascular risk. Nevertheless, cardiac rehabilitation interventions limit barriers in low utilization, further exacerbated by the restrictions associated with the COVID-19 pandemic. Therefore, it is essential to integrate alternative interventions such as telehealth, which can overcome several barriers. This literature review was designed as a framework for developing and evaluating telehealth interventions and mobile applications for comprehensive cardio-oncology rehabilitation. We identify knowledge gaps and propose strategies to facilitate the development and integration of cardio-oncology rehabilitation telehealth as an alternative approach to the standard of care for cancer patients and survivors. Despite the limited evidence, the pilot results from included studies support the feasibility and acceptability of telehealth and mobile technologies in cardio-oncology rehabilitation. This new area suggests that telehealth interventions are feasible and induce physiological and psychological benefits for cancer patients and survivors. There is an assumption that telehealth interventions and exercise may be an effective future alternative approach in supportive cancer care.
Introduction
Cardiovascular disease (CVD) and cancer remain the world’s leading and second leading causes of death in high-income developed countries (1). The direct toxicity of cancer treatment threatens patients and survivors with an increased risk of CVD, both during acute cancer treatment and during remission and subsequent survival (2). Chemotherapy treatment is associated with adverse functional changes in the left ventricle and, depending on the dose, risk for progression of heart failure and cardiovascular complications (3, 4). Radiation therapy and its effects can cause premature ischemic heart disease. In particular, radiation therapy targeted to the thoracic part of the body may increase cardiovascular complications, as typical in lung and breast cancer (5). Anti-tumor immunotherapy has also been found to involve a higher risk of autoimmune development of pericarditis or myocarditis (6). Further long-term observation is needed to determine the effects of this new treatment on the cardiovascular system. Therapeutic monoclonal antibodies and kinase inhibitors that target the protein function of tumor cells have side effects on the cardiovascular system as well. In addition, these side effects may occur in the acute phase of treatment or the long term after treatment and cause cardiac remodeling with the progression of cardiovascular disorders (7). Therefore, there is a need to investigate the cause of cardiac remodeling and develop optimal preventive strategies.
In the population of cancer patients and survivors, cardiovascular risk factors (hypertension, diabetes, dyslipidemia) are increasing, often in combination with an unhealthy lifestyle (obesity, smoking, and reduced fitness) (8). Cancer survivors have been found to have a several-fold increased incidence of cardiovascular risk factors (9), and this condition causes a higher risk of premature morbidity and mortality. To mitigate the risk, it has recently been strongly recommended to integrate a model of comprehensive cardiac rehabilitation, also called Cardio-Oncology REhabilitation (CORE), for the population of cancer patients and survivors (10–12).
Exercise is a crucial component of supportive care to reduce cardiovascular events and is associated with a lower risk of cancer progression and improved survival after a cancer diagnosis (13, 14). Furthermore, regular exercise improves cardiorespiratory fitness (CRF), quality of life and reduces fatigue in cancer survivors (15). Among the various training modalities for cancer survivals, one can highlight exercise programs or classes either as an individual or as a group (16), including a combination of aerobic, resistance, and flexibility exercises (17), balance (18, 19), dance (20), couples-based intervention (21), likewise stationary cycle (22) or complementary and alternative medicine approach (23). Most interventions occur in hospitals, academic settings, churches, and other community-based locations (24, 25). However, cardiac rehabilitation (CR) interventions have their barriers in the form of low utilization (26), further worsened by the limitations associated with the COVID-19 pandemic and elective care limitations (27, 28). Indeed, there is a need to integrate telehealth interventions in this area, increasing access to resources and care for patients in rural areas (29).
This literature review proposes a framework for developing and evaluating telehealth interventions and mobile applications for the comprehensive CORE for patients with cancer and survivors. We discuss the role of exercise in preventing or alleviating cardiovascular events modifying CVD risk factors and CRF. Lastly, we identify knowledge gaps and propose strategies to facilitate the development and integration of telehealth CORE as an alternative to standard care approach for cancer patients and survivors.
Key Components of the Core
Recent clinical practice recommendations for preventing and monitoring the burden of treatment side effects on the heart of cancer survivors suggest that cancer patients treated with anthracyclines should be further examined and considered for risk assessment (Figure 1). The CORE model was developed to identify patients at risk for CVD, including side effects of cancer treatment on the cardiovascular system, and integrate a multicomponent CR approach to preventing and reducing cardiovascular risk (30). The individual key preventive components of the CORE are medical assessment, nutritional counseling, management of blood lipids, diabetes, blood pressure, weight management, smoking cessation, psychosocial management, exercise, and physical activity guidance (Table 1).
Figure 1. Pre-CORE process.
Figure 1 illustrates a proposal of the process for cancer patients and survivors who could significantly benefit from the established multidisciplinary CORE. Patients with chemotherapy, radiotherapy, or CVD risk factors are targeted populations (31). The process represents the recommended concept for cardiovascular risk assessment (medical history and symptoms) at the CORE baseline—this combination of cardiological and oncological assessment during treatment or in remission for cancer patients and survivors. At the CORE baseline, it is essential to evaluate the safety of exercise using the cardiopulmonary exercise test to estimate the functional capacity and the presence of comorbidities associated with cancer and treatment (especially fatigue, pain, nausea, neuropathy, muscle loss, risk of falls, or depressive symptoms) (32).
The symptom-limited cardiopulmonary exercise test is the gold standard for measuring cardiorespiratory fitness in CR (33). The cardiopulmonary exercise test also facilitates assessing physiological response to exercise load, examination of cardiovascular disorders incidence, and provides limitations for prescription evidence-based exercise based on the Frequency, Intensity, Time, and Type (FITT) principle (34). Current research evidence supports the potential of exercise interventions for cancer patients to improve physical fitness (functional capacity, CRF), muscle strength, and body composition (35, 36). Indeed, patient’s exercise outcomes may differ due to side effects of the cancer treatment (fatigue, anemia) (37).
A functional capacity assessment can provide valuable information also during ongoing cancer treatment. A 6-min walk test (6MWT) is a suitable alternative to evaluate the submaximal capacity both in cardiac and cancer (38) patients before starting CR, CORE, or serially during cancer treatment (39). In several areas of cancer treatment, 6MWT to monitor patients and survivors was used for risk of decline in physical functioning during cancer treatment and subsequently in remission (40). Multidisciplinary CR centers could be an experienced potential partner in integrating CORE. However, centers may be exposed to different issues compared to the usual population of cardiac patients. Therefore, the CR team (physician, physiotherapist, or cardiovascular nurse) should be well educated and experienced in assessing the patient’s health and needs according to the specific type and possible side effects of cancer treatment. It is also appropriate to include oncological consultation in the concept of CORE programs. Table 1 displays a proposed process combining specific assessment in cancer patients and CR core/key preventive components (10).
Recommendations for Exercise Training in Cancer Survivors
Several international organizations have issued evidence-based exercise guidelines for cancer patients and survivors. The Physical Activity Guidelines Advisory Committee (PAGAC) (41) addressed the following question: What is the relationship between physical activity and specific cancer incidence? The PAGAC evaluated 45 systematic reviews, meta-analyses, and pooled analyses comprising hundreds of epidemiologic studies with several million participants (42). The PAGAC determined that, when comparing the incidence among individuals in the highest category of physical activity with individuals in the lowest, strong evidence demonstrated reduced risks of bladder, breast, colon, endometrial, esophageal adenocarcinoma, renal and gastric cancers, with relative risk reductions ranging from approximately 10 to 20%. The World Health Organization commissioned a similar report (in 2020) (43). More than 450 studies have been conducted that have examined some aspect of physical activity and its relationship to cancer risk, and dozens of meta-analyses and systematic reviews have been published that have examined the associations for specific cancer sites.
Moreover, exercise training for survivors has been identified as a generally feasible and safe approach (44–46). Based on the guidelines, there is strong evidence for tailor-made exercise programs currently associated with the COVID-19 pandemic, supporting the need to integrate a telehealth approach (47, 48).
An example of a concept for developing an individualized exercise prescription for remotely monitored CORE cancer survivors is shown below. The FITT exercise prescription consists of a 30–60 min exercise with a frequency of three sessions per week for at least 8 weeks. The recommended aerobic exercise intensity is 60–85% of maximum heart rate based on baseline exercise testing intensity or using Rate of Perceived Exertion (RPE) in the range of 12–13 degrees of the Borg scale (0–20). The strength training prescription should include 2–3 sessions per week, with two series of 8–12 repetitions at the intensity of 60–75% of the 1-Repetition Maximum in the range of 13–15 RPE (46).
The exercise session starts with a 5–10 min low-intensity warm-up and ends with a 5–10 min cool-down low-intensity phase and stretching exercises. Usually, walking or cycling exercise modalities are recommended for the aerobic part and weights or resistance bands for the strength training. Further is essential to avoid physical inactivity and achieve 150 min of moderate to vigorous-intensity aerobic activity (46). Indeed, the FITT exercise prescription should respect current CRF levels, cancer treatment, cardiovascular risk of exercise-related events, and the risk of falls or fractures of the patients. The initial dose of exercise and additional sessions should be progressive. Finally, behavioral change strategies target achieving a sustainable and long-term exercise regime (49).
Integration of Cardiac Rehabilitation in Supportive Cancer Care
One of the leading causes of death among cancer survivors is CVD (50). Long-term follow-up studies of cancer survivors in adults have stressed CVD as a competing risk and the necessity for pre-treatment CVD risk factor assessment, monitoring during treatment, and post-treatment care (51–53). Practical and feasible therapies are required to reduce CVD risk in cancer patients. A delivery approach similar to CR programs could be feasible (10, 54). Cancer rehabilitation programs are proactive approaches to the physical and/or functional decline of the patients associated with cancer or the cancer treatment process (55). On the other hand, CR is described as “the provision of comprehensive long-term therapies comprising medical evaluation, prescription exercise, cardiac risk factor management, and education, counseling, and behavioral interventions,” according to the American Heart Association (AHA) and has become an evidence-based practice guideline for the secondary prevention of ischemic heart disease (10, 11, 56, 57). Although CR is a cost-effective therapy (58, 59), it is underutilized (60–63), programs in place to improve referral and participation by including virtual models for CR outside of the traditional center-based approach (64). As a result, a scientific rationale for integrating cancer rehabilitation and CR is urgent to achieve the growing clinical needs for cancer-related or cancer-treatment-related CVD (10). The existing infrastructure of CR was acknowledged as a suitable model for cancer patients and survivors. The AHA introduces the integration idea and recommends the CORE framework (10). In addition, exercise may be beneficial in some types of cancer (breast, colon, lung, prostate, lymphomas, and other hematological diseases) when the associated cardiovascular risk is not negligible enough to exploit CR’s therapeutic action fully. Finally, improving CRF may provide benefits in terms of cancer-related symptom alleviation, mortality reduction, and/or cancer recurrence (10, 65, 66). Cancer treatment induces (besides direct cardiotoxicity) potential damage to the cardiovascular system by causing hormone deficits, alterations in insulin sensitivity, lipid metabolism, and inflammatory state. By fostering the development of metabolic syndrome, these alterations can exacerbate cardiometabolic risk (67, 68). The CORE is the ideal strategy for the prevention of these disorders. In subjects with a history of CVD, fasting total cholesterol, high/low-density lipoprotein, and triglyceride levels should be assessed during CORE, with a target of a low-density lipoprotein level below 70 mg/dL (66). Although a CVD risk score is beneficial (69), cancer-related variables such as chest and mediastinal irradiation must be considered when customizing individual cardiovascular risk (52, 70). The CORE team will create a customized aerobic and resistance training program to meet the target objectives.
Telehealth Core Feasibility for Cancer Patients and Survivors
Recently, a growing trend has been identified in studies addressing the feasibility, safety, and effect of telehealth exercise interventions in delivering supportive care for cancer patients and survivors (Table 2); only nine studies were included for this review, which illustrates the work’s “early” nature.
Table 2. Characteristics and results of studies that evaluated the effects of home-based exercise intervention.
For example, Galian-Castillo et al. (71) reported that among the 81 breast cancer survivors, aerobic and resistance exercises performed three times a week under telerehabilitation supervision led to a significant improvement in 6MWT (p < 0.001), quality of life (p < 0.001), pain severity (p < 0.001), and fatigue (p < 0.001) (71, 72). In another study, prostate cancer survivors who participated in home-based aerobic exercise three times a week with regular teleconsultations significantly improved CRF (p < 0.01) and body composition in the form of fat loss (p < 0.05) (73). Furthermore, Ariza-Garcia et al. (74) reported that during chemotherapy treatment, in 68 patients with breast cancer who participated in an 8-week Web-Based Exercise System intervention improved 6MWT (p < 0.05) and abdominal, back, and lower body strength (p < 0.001) (74).
In summary, telehealth exercise and/or physical activity intervention models are feasible, safe, and have shown good adherence. The findings from this review suggest that exercise can provide a variety of benefits for cancer survivors during the rehabilitation period after discharge from the hospital (Figure 2). Due to the combined effects of cancer treatment, which increase the risk of morbidity and mortality, there is good reason to identify at-risk groups of patients and survivors who provide individualized exercise interventions, especially those with barriers to accessing centralized services.
Figure 2. Potential telehealth exercise benefits in cancer patients and survivors. Exercise training can be an effective intervention for attenuating treatment and treatment-related cardiovascular disease prevention.
The Target Population for Core
There are no consensus recommendations for therapies to prevent all cancer treatment-related CVD risks. Patients with multiple cardiovascular risk factors, including patients at high risk for cancer treatment (radiotherapy or high-dose chemotherapy) and adult survivors after high-exposure childhood cancer treatment, are likely to benefit the most from CORE (81). Recent AHA scientific statements aimed at preventing and managing cardiac dysfunction of post-treatment cancer patients and survivors identified evidence-based recommendations for selected cancer therapies and exposures predisposing to cardiac dysfunction (10). Indeed, referenced guidelines are only a starting point for recommendations. Multidisciplinary expertise cooperation (internal, cardiology/oncology) is required to assess the risk of cancer treatment-related CVD, which will vary depending on the type and intensity of treatment, medical history, cardiovascular risk factors, and patient age.
Patients who meet one of the criteria listed below are considered high risk for cancer-related CVD:
• Treatment with high doses of anthracyclines (doxorubicin ≥ 250 mg/m2)
• High-dose radiation (≥30 Gy if targeted to the chest)
• Combination: low doses of radiation and low doses of anthracyclines
• Combination: treatment with low doses of anthracyclines plus ≥ 2 cardiovascular risk factors (hypertension, diabetes, dyslipidemia, metabolic syndrome, obesity, smoking) plus older age (60+) or presence of CVD (history of coronary heart disease, cardiac failure, reduced left ventricular function)
• Treatment with lower doses of anthracyclines followed by trastuzumab
The rationale for comprehensive telehealth CORE Until now, the focus of cancer survivors has been investigating the presence of cardiotoxic-induced cardiac dysfunction. However, the side effects of cancer treatment extend beyond the cardiovascular system. Indeed, it has been found that CRF and assessment of cardiopulmonary function may have prognostic significance in cancer patients (82, 83). Metanalysis has shown that CRF decreases during exposure to combination anticancer treatment (84), and development may not reverse after treatment. Low CRF has been identified in several survivors, such as lung, cervical, endometrial, and ovarian cancers or young adult cancer survivors (85–88). Thus, a growing need to include an exercise training strategy to prevent CRF decrease during anticancer treatment (89). Exercise training is one of the most important components of comprehensive CR, leading to increases in CRF and reducing cardiovascular morbidity and mortality (90, 91). Therefore, there is an assumption that the implication of implementing comprehensive CORE may represent significant physiological and psychological benefits for cancer patients and survivors.
Recently, several studies have integrated CR exercise interventions and demonstrated effectivity on CRF and other cardiovascular outcomes in various cancer populations during and after primary adjuvant therapy. A meta-analysis of 1990 patients intervened by exercise training after completion of cancer treatment recorded a significant increase in CRF compared to 1,642 patients in usual care by peak oxygen consumption + 2.13 ml/kg/min (95% CI, 1.58–2.67 ml/kg/min; p < 0.001) (92). In short, exercise training can positively affect the decrease in CRF induced by cancer treatment and improve CRF upon completion of cancer treatment. Developing and implementing novel approaches, such as telehealth CORE, would increase participation utilization by expanding capacity (93, 94). Another essential benefit is cost-effectiveness, especially for patients requiring direct exercise supervision (95). The telehealth CORE provides components that are comparable to the supervised center-based CORE. However, there are limitations in that CR staff are not comprehensively trained in cancer treatment and supportive care. Indeed, the responsibility for identifying and referring cancer patients at risk for cardiac dysfunction remains in the hands of oncologists and internal medicine physicians. Although cardio-oncology collaboration usually begins with cardiovascular disorders, a proactive clinical specialist collaboration is needed to develop a comprehensive CORE.Lastly, the World Health Organization statement also recommended following the patient-centered approach and considering individualized treatment and patient preferences in the telehealth interventions (96). The theory assumes that prescription adherence can be improved by designing intervention programs according to the preferences and needs of patients. Indeed, it was identified that patient preferences could affect treatment outcomes (97). In addition, a recent study found that eligible patients for CR were given the choice of a home-based or center-based intervention, with almost half preferring a home-based approach (98). Therefore, evaluating patient preferences is essential to developing comprehensive patient-centered strategies.
Key activities and strategies for telehealth CORE include: (i) identifying patient preferences (can be individual at different stages of treatment), (ii) determining safety by assessing the risk of exercise-related adverse events, (iii) secure communication links with the patient versus CORE center (smartphone apps, web-based-platforms, wearable tracking systems, and sensors), (iv) home-based exercise prescription (with a particularemphasis on individual response to dose and type of exercise), and (v) provide patient self-directed plan feedback (monitoring exercise progress, adherence to exercise prescription and nutrition plans, motivational support and adaptations).
Research Gaps and Future Directions
According to the latest findings, telehealth and mobile technology-based interventions should incorporate individual patient assessment, exercise training, physical activity consultation, self-management of modifiable risk factors, and psychological counseling (99, 100). Nevertheless, the optimal combination and importance of the individual preventive components required to maximize the effect of telehealth and mobile applications remain unclear and form a crucial field for future research (101).
Secondly, regular physical activity improves cardiovascular health outcomes. Although a questionnaire survey is a standard method of assessing physical activity, it was found to show a high degree of variability compared to objectively measured physical activity (102). Thus, mobile technologies and telehealth provide a suitable alternative, as physical activity can be recorded and reported on real-time platforms. In addition, mobile devices provide opportunities to interface with pedometers, wearable sensors, accelerometers, and other wireless technologies that track physical activity and exercise.
It is also essential to consider the psychological needs of cancer patients. The prevalence of distress in patients with cancer ranges from 35 to 55%. Lack of control over treatment decisions also plays a part in the onset of depression, sadness, anxiety, and decreased quality of life. Preliminary reports indicate that home-based exercise interventions may provide physiological and psychological benefits for cancer survivors (103). However, limited studies have been conducted on modern technology in the psychotherapeutic process. It has also been shown that stressed patients tolerate therapy less well, while motivated patients who adhere to the rehabilitation program achieve better health results. The complementation of rehabilitation with immersive virtual reality therapy systems or psychotherapeutic teleconsultations may provide vital support for patients. However, specific requirements must be met for remote systems to help improve the mental state of patients. Such a system should address therapeutic factors such as breathing exercises, relaxation, mindfulness, or elements of psychotherapy.
Telemental health is currently the most widely used telemedicine option. Indeed, visualization as a therapeutic method may boost the immune system (104). This technology has gained the most popularity and effectiveness in treating depression, anxiety disorders, and post-traumatic stress disorder (105). Thus, virtual technology supplemented with telemental health projects has the potential to make healthcare more efficient.
Moreover, further investigations could be integrated into a comprehensive, remotely guided examination with other wearable sensors such as heart rate, ECG, blood pressure, body weight, or glycemia. Future perspectives and research should aim to analyze the validity and reliability of sensors and develop valuable benchmarks for assessing outcomes in the prevention and supportive cancer care associated with mobile technologies.
Furthermore, there is a need to address concerns related to the legal clarity of telehealth services provision. It is also unclear what effect telehealth and mobile technologies will have on the overall cost of supportive cancer care (106). While mobile technology and information and communication technology services can be costly in terms of direct cost, in the beginning, the potential benefits of efficacy and acceptability on the patient side can provide more significant benefits.
Finally, analyses and large-scale feasibility evaluations are needed to prevent patients from dropping out of telehealth interventions. Therefore, conducting clinical feasibility evaluations of the telehealth or mobile app concept is recommended using usability testing and field studies to analyze qualitative and quantitative characteristics of efficacy, safety, adherence, and user satisfaction.
Conclusion
Cancer patients and survivors are under-represented in current cardiovascular prevention studies. Given the available evidence on CVD risk in cancer patients and the possible risk reduction through CORE, there is a need to develop patient-centered interventions to increase participation and utilization. Although there is limited evidence, pilot results support the feasibility and acceptability of telehealth and mobile technologies in CORE cancer patients and survivors. This new area suggests that telehealth interventions can induce physiological and psychological benefits in cancer patients and survivors. Therefore, telehealth intervention and exercise may be an alternative approach to standard cancer care in the future.
Author Contributions
All authors listed have made a substantial, direct, and intellectual contribution to the work and approved it for publication.
Funding
This research was funded by the Ministry of Health, Czechia; Conceptual Development of Research Organization (FNBr, 65269705).
Conflict of Interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Publisher’s Note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
References
1. Yusuf S, Joseph P, Rangarajan S, Islam S, Mente A, Hystad P, et al. Modifiable risk factors, cardiovascular disease, and mortality in 155 722 individuals from 21 high-income, middle-income, and low-income countries (PURE): a prospective cohort study. Lancet. (2020) 395:795–8. doi: 10.1016/S0140-6736(19)32008-2
2. Han X, Zhou Y, Liu W. Precision cardio-oncology: understanding the cardiotoxicity of cancer therapy. NPJ Precis Oncol. (2017) 12:31. doi: 10.1038/s41698-017-0034-x
3. Bloom MW, Hamo CE, Cardinale D, Ky B, Nohria A, Baer L, et al. Cancer therapy-related cardiac dysfunction and heart failure: part 1: definitions, pathophysiology, risk factors, and imaging. Circ Heart Fail. (2016) 9:e002661. doi: 10.1161/CIRCHEARTFAILURE.115.002661
4. Babiker HM, McBride A, Newton M, Boehmer LM, Drucker AG, Gowan M, et al. Cardiotoxic effects of chemotherapy: a review of both cytotoxic and molecular targeted oncology therapies and their effect on the cardiovascular system. Crit Rev Oncol Hematol. (2018) 126:186–200. doi: 10.1016/j.critrevonc.2018.03.014
5. Banfill K, Giuliani M, Aznar M, Franks K, McWilliam A, Schmitt M, et al. Cardiac toxicity of thoracic radiotherapy: existing evidence and future directions. J Thorac Oncol. (2021) 16:216–27. doi: 10.1016/j.jtho.2020.11.002
6. Maisch B. Cardio-immunology of myocarditis: focus on immune mechanisms and treatment options. Front Cardiovasc Med. (2019) 12:48. doi: 10.3389/fcvm.2019.00048
7. Kumar M, Thangavel C, Becker RC, Sadayappan S. Monoclonal antibody-based immunotherapy and its role in the development of cardiac toxicity. Cancers. (2020) 13:86. doi: 10.3390/cancers13010086
8. Koene RJ, Prizment AE, Blaes A, Konety SH. Shared risk factors in cardiovascular disease and cancer. Circulation. (2016) 133:1104–14. doi: 10.1161/CIRCULATIONAHA.115.020406
9. Strongman H, Gadd S, Matthews A, Mansfield KE, Stanway S, Lyon AR, et al. Medium and long-term risks of specific cardiovascular diseases in survivors of 20 adult cancers: a population-based cohort study using multiple linked UK electronic health records databases. Lancet. (2019) 394:1041–54. doi: 10.1016/S0140-6736(19)31674-5
10. Gilchrist SC, Barac A, Ades PA, Alfano CM, Franklin BA, Jones LW, et al. Cardio-oncology rehabilitation to manage cardiovascular outcomes in cancer patients and survivors: a scientific statement from the American heart association. Circulation. (2019) 139:e997–1012. doi: 10.1161/CIR.0000000000000679
11. Venturini E, Iannuzzo G, D’Andrea A, Pacileo M, Tarantini L, Canale ML, et al. Oncology and cardiac rehabilitation: an underrated relationship. J Clin Med. (2020) 9:1810. doi: 10.3390/jcm9061810
12. Kang DW, Wilson RL, Christopher CN, Normann AJ, Barnes O, Lesansee JD, et al. Exercise cardio-oncology: exercise as a potential therapeutic modality in the management of anthracycline-induced cardiotoxicity. Front Cardiovasc Med. (2022) 8:805735. doi: 10.3389/fcvm.2021.805735
13. Thomas R, Kenfield SA, Yanagisawa Y, Newton RU. Why exercise has a crucial role in cancer prevention, risk reduction and improved outcomes. Br Med Bull. (2021) 139:100–19. doi: 10.1093/bmb/ldab019
14. Patel AV, Friedenreich CM, Moore SC, Hayes SC, Silver JK, Campbell KL, et al. American college of sports medicine roundtable report on physical activity, sedentary behavior, and cancer prevention and control. Med Sci Sports Exerc. (2019) 51:2391–402. doi: 10.1249/MSS.0000000000002117
15. Thorsen L, Skovlund E, Strømme SB, Hornslien K, Dahl AA, Fosså SD. Effectiveness of physical activity on cardiorespiratory fitness and health-related quality of life in young and middle-aged cancer patients shortly after chemotherapy. J Clin Oncol. (2005) 23:2378–88. doi: 10.1200/JCO.2005.04.106
16. Conlon BA, Kahan M, Martinez M, Hornslien K, Dahl AA, Fosså SD. Development and evaluation of the curriculum for BOLD (bronx oncology living daily) healthy living: a diabetes prevention and control program for underserved cancer survivors. J Cancer Educ. (2015) 30:535–45. doi: 10.1007/s13187-014-0750-7
17. Strasser B, Steindorf K, Wiskemann J, Ulrich CM. Impact of resistance training in cancer survivors: a meta-analysis. Med Sci Sports Exerc. (2013) 45:2080–90. doi: 10.1249/MSS.0b013e31829a3b63
18. Schwenk M, Grewal GS, Holloway D, Muchna A, Garland L, Najafi B. Interactive sensor-based balance training in older cancer patients with chemotherapy-induced peripheral neuropathy: a randomized controlled trial. Gerontology. (2016) 62:553–63. doi: 10.1159/000442253
19. Jastrzębski D, Żebrowska A, Rutkowski S, Rutkowska A, Warzecha J, Ziaja B, et al. Pulmonary rehabilitation with a stabilometric platform after thoracic surgery: a preliminary report. J Hum Kinet. (2018) 65:79–87. doi: 10.2478/hukin-2018-0044
20. Pisu M, Demark-Wahnefried W, Kenzik KM, Oster RA, Lin CP, Manne S, et al. A dance intervention for cancer survivors and their partners (RHYTHM). J Cancer Surviv. (2017) 11:350–9. doi: 10.1007/s11764-016-0593-9
21. Carmack CL, Parker NH, Demark-Wahnefried W, Shely L, Baum G, Yuan Y, et al. Healthy moves to improve lifestyle behaviors of cancer survivors and their spouses: feasibility and preliminary results of intervention efficacy. Nutrients. (2021) 13:4460. doi: 10.3390/nu13124460
22. Zhou Y, Zhu J, Gu Z, Yin X. Efficacy of exercise interventions in patients with acute leukemia: a meta-analysis. PLoS One. (2016) 11:e0159966. doi: 10.1371/journal.pone.0159966
23. Mao JJ, Palmer CS, Healy KE, Desai K, Amsterdam J. Complementary and alternative medicine use among cancer survivors: a population-based study. J Cancer Surviv. (2011) 5:8–17. doi: 10.1007/s11764-010-0153-7
24. Winters-Stone KM, Lyons KS, Dieckmann NF, Bennett JA, Nail L, Dobek J, et al. Benefits of partnered strength training for prostate cancer survivors and spouses: results from a randomized controlled trial of the exercising together project. J Cancer Surviv. (2016) 10:633–44. doi: 10.1007/s11764-015-0509-0
25. Barber FD. Effects of social support on physical activity, self-efficacy, and quality of life in adult cancer survivors and their caregivers. Oncol Nurs Forum. (2013) 40:481–9. doi: 10.1188/13.ONF.481-489
26. Winnige P, Filakova K, Hnatiak J, Dosbaba F, Bocek O, Pepera G, et al. Validity and reliability of the cardiac rehabilitation barriers scale in the czech republic (CRBS-CZE): determination of key barriers in east-central Europe. Int J Environ Res Public Health. (2021) 18:13113. doi: 10.3390/ijerph182413113
27. Dunlay SM, Witt BJ, Allison TG, Hayes SN, Weston SA, Koepsell E, et al. Barriers to participation in cardiac rehabilitation. Am Heart J. (2009) 158:852–9. doi: 10.1016/j.ahj.2009.08.010
28. Stefanakis M, Batalik L, Papathanasiou J, Dipla L, Antoniou V, Pepera G. Exercise-based cardiac rehabilitation programs in the era of COVID-19: a critical review. Rev Cardiovas Med. (2021) 22:1143–55. doi: 10.31083/j.rcm2204123
29. Gajarawala SN, Pelkowski JN. Telehealth benefits and barriers. J Nurse Pract. (2021) 17:218–21. doi: 10.1016/j.nurpra.2020.09.013
30. Tong CKW, Lau B, Davis MK. Exercise training for cancer survivors. Curr Treat Options Oncol. (2020) 21:53. doi: 10.1007/s11864-020-00752-w
31. Venturini E, Gilchrist S, Corsi E, Di Lorenzo A, Cuomo G, D’Ambrosio G, et al. The core components of cardio-oncology rehabilitation. Panminerva Med. (2021) 63:170–83. doi: 10.23736/S0031-0808.21.04303-2
32. Pepera GK, Bromley PD, Sandercock GRH. A pilot study to investigate the safety of exercise training and exercise testing in cardiac rehabilitation patients. Br J Cardiol. (2013) 20:78. doi: 10.5837/bjc.2013.012
33. Balady GJ, Arena R, Sietsema K, Myers J, Coke L, Fletcher GF, et al. Clinician’s guide to cardiopulmonary exercise testing in adults: a scientific statement from the American heart association. Circulation. (2010) 122:191–225. doi: 10.1161/CIR.0b013e3181e52e69
34. Jones LW, Eves ND, Peppercorn J. Pre-exercise screening and prescription guidelines for cancer patients. Lancet Oncol. (2010) 11:914–6. doi: 10.1016/S1470-2045(10)70184-4
35. De Lazzari N, Niels T, Tewes M, Götte M. A systematic review of the safety, feasibility and benefits of exercise for patients with advanced cancer. Cancers. (2021) 13:4478. doi: 10.3390/cancers13174478
36. Maginador G, Lixandrão ME, Bortolozo HI, Vechin FC, Sarian LO, Derchain S, et al. Aerobic exercise-induced changes in cardiorespiratory fitness in breast cancer patients receiving chemotherapy: a systematic review and meta-analysis. Cancers. (2020) 12:2240. doi: 10.3390/cancers12082240
37. Clifford B, Koizumi S, Wewege MA, Leake HB, Ha L, Macdonald E, et al. The effect of resistance training on body composition during and after cancer treatment: a systematic review and meta-analysis. Sports Med. (2021) 51:2527–46. doi: 10.1007/s40279-021-01542-6
38. Pepera G, Ingle L, Sandercock GR. Predictors of the 6-minute walk test in patients with chronic heart failure. Br J Cardiac Nurs. (2015) 10:454–9. doi: 10.12968/bjca.2015.10.9.454
39. Schmidt K, Vogt L, Thiel C, Jäger E, Banzer W. Validity of the six-minute walk test in cancer patients. Int J Sports Med. (2013) 34:631–6. doi: 10.1055/s-0032-1323746
40. Tubiana-Mathieu N, Cornette T, Mandigout S, Leobon S, Vincent F, Venat L, et al. Can the six-minute walk test be used to individualize physical activity intensity in patients with breast cancer? Cancers. (2021) 13:5851. doi: 10.3390/cancers13225851
41. 2018 Physical Activity Guidelines Advisory Committee. Physical Activity Guidelines Advisory Committee Scientific Report. Washington, DC: U.S. Department of Health and Human Services (2018).
42. McTiernan A, Friedenreich CM, Katzmarzyk PT, Powell KE, Macko R, Buchner D, et al. Physical activity in cancer prevention and survival: a systematic review. Med Sci Sports Exerc. (2019) 51:1252–61. doi: 10.1249/MSS.0000000000001937
43. Wild C, Weiderpass E, Steward BW. World Cancer Report: Cancer Research for Cancer Prevention. Lyon: International Agency for Research on Cancer (2020).
44. Schmitz KH, Campbell AM, Stuiver MM, Pinto BM, Schwartz AL, Morris GS, et al. Exercise is medicine in oncology: engaging clinicians to help patients move through cancer. CA Cancer J Clin. (2019) 69:468–84. doi: 10.3322/caac.21579
45. Pudil R, Mueller C, Čelutkienė J, Henriksen PA, Lenihan D, Dent S, et al. Role of serum biomarkers in cancer patients receiving cardiotoxic cancer therapies: a position statement from the cardio-oncology study group of the heart failure association and the cardio-oncology council of the European society of cardiology. Eur J Heart Fail. (2020) 22:1966–83. doi: 10.1002/ejhf.2017
46. Campbell KL, Winters-Stone KM, Wiskemann J, May AM, Schwartz AL, Courneya KS, et al. Exercise guidelines for cancer survivors: consensus statement from international multidisciplinary roundtable. Med Sci Sports Exerc. (2019) 51:2375–90. doi: 10.1249/MSS.0000000000002116
47. Scherrenberg M, Wilhelm M, Hansen D, Völler H, Cornelissen V, Frederix I, et al. The future is now: a call for action for cardiac telerehabilitation in the COVID-19 pandemic from the secondary prevention and rehabilitation section of the European association of preventive cardiology. Eur J Prev Cardiol. (2020) 2:2047487320939671. doi: 10.1177/2047487320939671
48. Batalik L, Winnige P, Dosbaba F, Vlazna D, Janikova A. Home-based aerobic and resistance exercise interventions in cancer patients and survivors: a systematic review. Cancers. (2021) 13:1915. doi: 10.3390/cancers13081915
49. Hudis CA, Jones L. Promoting exercise after a cancer diagnosis: easier said than done. Br J Cancer. (2014) 110:829–30. doi: 10.1038/bjc.2014.12
50. Armstrong GT, Chen Y, Yasui Y, Leisenring W, Gibson TM, Mertens AC, et al. Reduction in late mortality among 5-year survivors of childhood cancer. N Engl J Med. (2016) 374:833–42. doi: 10.1056/NEJMoa1510795
51. Armenian SH, Xu L, Ky B, Sun C, Farol LT, Pal SK, et al. Cardiovascular disease among survivors of adult-onset cancer: a community-based retrospective cohort study. J Clin Oncol. (2016) 34:1122–30. doi: 10.1200/JCO.2015.64.0409
52. Patnaik JL, Byers T, DiGuiseppi C, Dabelea D, Denberg TD. Cardiovascular disease competes with breast cancer as the leading cause of death for older females diagnosed with breast cancer: a retrospective cohort study. Breast Cancer Res. (2011) 13:R64. doi: 10.1186/bcr2901
53. Yeh JM, Ward ZJ, Chaudhry A, Liu Q, Yasui Y, Armstrong GT, et al. Life expectancy of adult survivors of childhood cancer over 3 decades. JAMA Oncol. (2020) 6:350–7. doi: 10.1001/jamaoncol.2019.5582
54. Wenger NK, Froelicher ES, Smith LK, Ades PA, Berra K, Blumenthal JA, et al. Cardiac rehabilitation as secondary prevention. Agency for health care policy and research and national heart, lung, and blood institute. Clin Pract Guidel Quick Ref Guide Clin. (1995) 17:1–23.
55. Stout NL, Alfano CM, Belter CW, Nitkin R, Cernich A, Lohmann Siegel K, et al. A bibliometric analysis of the landscape of cancer rehabilitation research (1992-2016). J Natl Cancer Inst. (2018) 110:815–24. doi: 10.1093/jnci/djy108
56. Thomas RJ, King M, Lui K, Oldridge N, Piña IL, Spertus J, et al. Performance measures on cardiac rehabilitation for referral to cardiac rehabilitation/secondary prevention services: a report of the American association of cardiovascular and pulmonary rehabilitation and the American college of cardiology foundation/American heart association task force on performance measures (writing committee to develop clinical performance measures for cardiac rehabilitation). J Cardiopulm Rehabil Prev. (2010) 30:279–88. doi: 10.1097/HCR.0b013e3181f5e36f
57. Sandercock GRH, Cardoso F, Almodhy M, Pepera G. Cardiorespiratory fitness changes in patient receiving comprehensive outpatient cardiac rehabilitation in the United Kingdom: a multicentre study. Heart. (2012) 99:785–90. doi: 10.1136/heartjnl-2012-303055
58. Ades PA, Pashkow FJ, Nestor JR. Cost-effectiveness of cardiac rehabilitation after myocardial infarction. J Cardiopulm Rehabil Prev. (1997) 17:222–31. doi: 10.1097/00008483-199707000-00002
59. Anderson L, Thompson DR, Oldridge N, Zwisler AD, Rees K, Martin N, et al. Exercise-based cardiac rehabilitation for coronary heart disease. Cochrane Database Syst Rev. (2016) 2016:CD001800. doi: 10.1002/14651858.CD001800.pub3
60. Balady GJ, Williams MA, Ades PA, Bittner V, Comoss P, Foody JM, et al. Core components of cardiac rehabilitation/secondary prevention programs: 2007 update: a scientific statement from the American heart association exercise, cardiac rehabilitation, and prevention committee, the council on clinical cardiology; the councils on cardiovascular nursing, epidemiology and prevention, and nutrition, physical activity, and metabolism; and the American association of cardiovascular and pulmonary rehabilitation. Circulation. (2007) 115:2675–82. doi: 10.1161/CIRCULATIONAHA.106.180945
61. Giannuzzi P, Mezzani A, Saner H, Björnstad H, Fioretti P, Mendes M, et al. Position paper of the working group on cardiac rehabilitation and exercise physiology of the European society of cardiology. Eur J Cardiovasc Prev Rehabil. (2003) 10:319–27. doi: 10.1097/01.hjr.0000086303.28200.50
62. Piepoli MF, Corrà U, Adamopoulos S, Benzer W, Bjarnason-Wehrens B, Cupples M, et al. Secondary prevention in the clinical management of patients with cardiovascular diseases. core components, standards and outcome measures for referral and delivery: a policy statement from the cardiac rehabilitation section of the European association for cardiovascular prevention & rehabilitation. Endorsed by the committee for practice guidelines of the European society of cardiology. Eur J Prev Cardiol. (2014) 21:664–81. doi: 10.1177/2047487312449597
63. Suaya JA, Shepard DS, Normand SL, Ades PA, Prottas J, Stason WB. Use of cardiac rehabilitation by medicare beneficiaries after myocardial infarction or coronary bypass surgery. Circulation. (2007) 116:1653–62. doi: 10.1161/CIRCULATIONAHA.107.701466
64. Ades PA, Keteyian SJ, Wright JS, Hamm LF, Lui K, Newlin K, et al. Increasing cardiac rehabilitation participation from 20% to 70%: a road map from the million hearts cardiac rehabilitation collaborative. Mayo Clin Proc. (2017) 92:234–42. doi: 10.1016/j.mayocp.2016.10.014
65. Scott JM, Nilsen TS, Gupta D, Jones LW. Exercise therapy and cardiovascular toxicity in cancer. Circulation. (2018) 137:1176–91. doi: 10.1161/CIRCULATIONAHA.117.024671
66. Wittekind SG, Gilchrist SC. Exercise testing and cardiac rehabilitation in patients treated for cancer. J Thromb Thrombolysis. (2021) 51:870–6. doi: 10.1007/s11239-020-02265-7
67. Inoue-Choi M, Robien K, Lazovich D. Adherence to the WCRF/AICR guidelines for cancer prevention is associated with lower mortality among older female cancer survivors. Cancer Epidemiol Biomarkers Prev. (2013) 22:792–802. doi: 10.1158/1055-9965.EPI-13-0054
68. Miller KD, Siegel RL, Lin CC, Mariotto AB, Kramer JL, Rowland JH, et al. Cancer treatment and survivorship statistics, 2016. CA Cancer J Clin. (2016) 66:271–89. doi: 10.3322/caac.21349
69. Adams SC, DeLorey DS, Davenport MH, Stickland MK, Fairey AS, North S, et al. Effects of high-intensity aerobic interval training on cardiovascular disease risk in testicular cancer survivors: a phase 2 randomized controlled trial. Cancer. (2017) 123:4057–65. doi: 10.1002/cncr.30859
70. Mulrooney DA, Hyun G, Ness KK, Ehrhardt MJ, Yasui Y, Duprez D, et al. Major cardiac events for adult survivors of childhood cancer diagnosed between 1970 and 1999: report from the childhood cancer survivor study cohort. BMJ. (2020) 368:l6794. doi: 10.1136/bmj.l6794
71. Galiano-Castillo N, Cantarero-Villanueva I, Fernández-Lao C, Ariza-García A, Díaz-Rodríguez L, Del-Moral-Ávila R, et al. Telehealth system: a randomized controlled trial evaluating the impact of an internet-based exercise intervention on quality of life, pain, muscle strength, and fatigue in breast cancer survivors. Cancer. (2016) 122:3166–74. doi: 10.1002/cncr.30172
72. Galiano-Castillo N, Arroyo-Morales M, Lozano-Lozano M, Fernández-Lao C, Martín-Martín L, Del-Moral-Ávila R, et al. Effect of an internet-based telehealth system on functional capacity and cognition in breast cancer survivors: a secondary analysis of a randomized controlled trial. Support Care Cancer. (2017) 25:3551–9. doi: 10.1007/s00520-017-3782-9
73. Alibhai SMH, Santa Mina D, Ritvo P, Tomlinson G, Sabiston C, Krahn M, et al. A phase II randomized controlled trial of three exercise delivery methods in men with prostate cancer on androgen deprivation therapy. BMC Cancer. (2019) 19:2. doi: 10.1186/s12885-018-5189-5
74. Ariza-Garcia A, Lozano-Lozano M, Galiano-Castillo N, Postigo-Martin P, Arroyo-Morales M, Cantarero-Villanueva I. A web-based exercise system (e-CuidateChemo) to counter the side effects of chemotherapy in patients with breast cancer: randomized controlled trial. J Med Internet Res. (2019) 21:e14418. doi: 10.2196/14418
75. Cornette T, Vincent F, Mandigout S, Antonini MT, Leobon S, Labrunie A, et al. Effects of home-based exercise training on VO2 in breast cancer patients under adjuvant or neoadjuvant chemotherapy (SAPA): a randomized controlled trial. Eur J Phys Rehabil Med. (2016) 52:223–32.
76. Gehring K, Kloek CJ, Aaronson NK, Janssen KW, Jones LW, Sitskoorn MM, et al. Feasibility of a home-based exercise intervention with remote guidance for patients with stable grade II and III gliomas: a pilot randomized controlled trial. Clin Rehabil. (2018) 32:352–66. doi: 10.1177/0269215517728326
77. Hvid T, Lindegaard B, Winding K, Iversen P, Brasso K, Solomon TP, et al. Effect of a 2-year home-based endurance training intervention on physiological function and PSA doubling time in prostate cancer patients. Cancer Causes Control. (2016) 27:165–74. doi: 10.1007/s10552-015-0694-1
78. Cheville AL, Moynihan T, Herrin J, Loprinzi C, Kroenke K. Effect of collaborative telerehabilitation on functional impairment and pain among patients with advanced-stage cancer: a randomized clinical trial. JAMA Oncol. (2019) 5:644–52. doi: 10.1001/jamaoncol.2019.0011
79. Lahart IM, Carmichael AR, Nevill AM, Kitas GD, Metsios GS. The effects of a home-based physical activity intervention on cardiorespiratory fitness in breast cancer survivors; a randomised controlled trial. J Sports Sci. (2018) 36:1077–86. doi: 10.1080/02640414.2017.1356025
80. McNeil J, Brenner DR, Stone CR, O’Reilly R, Ruan Y, Vallance JK, et al. Activity tracker to prescribe various exercise intensities in breast cancer survivors. Med Sci Sports Exerc. (2019) 51:930–40. doi: 10.1249/MSS.0000000000001890
81. Morales JS, Valenzuela PL, Velázquez-Díaz D, Castillo-García A, Jiménez-Pavón D, Lucia A, et al. Exercise and childhood cancer–a historical review. Cancers. (2021) 14:82. doi: 10.3390/cancers14010082
82. Howden EJ, Bigaran A, Beaudry R, Fraser S, Selig S, Foulkes S, et al. Exercise as a diagnostic and therapeutic tool for the prevention of cardiovascular dysfunction in breast cancer patients. Eur J Prev Cardiol. (2019) 26:305–15. doi: 10.1177/2047487318811181
83. Jones LW, Hornsby WE, Goetzinger A, Forbes LM, Sherrard EL, Quist M, et al. Prognostic significance of functional capacity and exercise behavior in patients with metastatic non-small cell lung cancer. Lung Cancer. (2012) 76:248–52. doi: 10.1016/j.lungcan.2011.10.009
84. Jones LW, Liang Y, Pituskin EN, Battaglini CL, Scott JM, Hornsby WE, et al. Effect of exercise training on peak oxygen consumption in patients with cancer: a meta-analysis. Oncologist. (2011) 16:112–20. doi: 10.1634/theoncologist.2010-0197
85. Yu AF, Flynn JR, Moskowitz CS, Scott JM, Oeffinger KC, Dang CT, et al. Long-term cardiopulmonary consequences of treatment-induced cardiotoxicity in survivors of ERBB2-positive breast cancer. JAMA Cardiol. (2020) 5:309–17. doi: 10.1001/jamacardio.2019.5586
86. Peel AB, Barlow CE, Leonard D, DeFina LF, Jones LW, Lakoski SG. Cardiorespiratory fitness in survivors of cervical, endometrial, and ovarian cancers: the cooper center longitudinal study. Gynecol Oncol. (2015) 138:394–7. doi: 10.1016/j.ygyno.2015.05.027
87. Canada JM, Trankle CR, Carbone S, Buckley LF, Chazal M, Billingsley H, et al. Determinants of cardiorespiratory fitness following thoracic radiotherapy in lung or breast cancer survivors. Am J Cardiol. (2020) 125:988–96. doi: 10.1016/j.amjcard.2019.12.019
88. Morales JS, Valenzuela PL, Herrera-Olivares AM, Baño-Rodrigo A, Castillo-García A, Rincón-Castanedo C, et al. Exercise interventions and cardiovascular health in childhood cancer: a meta-analysis. Int J Sports Med. (2020) 41:141–53. doi: 10.1055/a-1073-8104
89. Klassen O, Schmidt ME, Scharhag-Rosenberger F, Sorkin M, Ulrich CM, Schneeweiss A, et al. Cardiorespiratory fitness in breast cancer patients undergoing adjuvant therapy. Acta Oncol. (2014) 53:1356–65. doi: 10.3109/0284186X.2014.899435
90. Hung RK, Al-Mallah MH, McEvoy JW, Whelton SP, Blumenthal RS, Nasir K, et al. Prognostic value of exercise capacity in patients with coronary artery disease: the FIT (henry ford exercise testing) project. Mayo Clin Proc. (2014) 89:1644–54. doi: 10.1016/j.mayocp.2014.07.011
91. Medina-Inojosa JR, Grace SL, Supervia M, Stokin G, Bonikowske AR, Thomas R, et al. Dose of cardiac rehabilitation to reduce mortality and morbidity: a population-based study. J Am Heart Assoc. (2021) 10:e021356. doi: 10.1161/JAHA.120.021356
92. Scott JM, Zabor EC, Schwitzer E, Koelwyn GJ, Adams SC, Nilsen TS, et al. Efficacy of exercise therapy on cardiorespiratory fitness in patients with cancer: a systematic review and meta-analysis. J Clin Oncol. (2018) 36:2297–305. doi: 10.1200/JCO.2017.77.5809
93. World Health Organization.Framework for the Implementation of a Telemedicine Service. (2016). Available online at: https://iris.paho.org/bitstream/handle/10665.2/28414/9789275119037_eng.pdf (accessed January 1, 2022).
94. Beatty AL, Fukuoka Y, Whooley MA. Using mobile technology for cardiac rehabilitation: a review and framework for development and evaluation. J Am Heart Assoc. (2013) 2:e000568. doi: 10.1161/JAHA.113.000568
95. Grustam AS, Severens JL, De Massari D, Buyukkaramikli N, Koymans R, Vrijhoef H. Cost-effectiveness analysis in telehealth: a comparison between home telemonitoring, nurse telephone support, and usual care in chronic heart failure management. Value Health. (2018) 21:772–82. doi: 10.1016/j.jval.2017.11.011
96. World Health Organization.Telemedicine Opportunities and Developments in Member States. (2009). Available online at: https://www.who.int/goe/publications/goe_telemedicine_2010.pdf (accessed January 1, 2022).
97. Varnfield M, Karunanithi M, Lee CK, Honeyman E, Arnold D, Ding H, et al. Smartphone-based home care model improved use of cardiac rehabilitation in postmyocardial infarction patients: results from a randomised controlled trial. Heart. (2014) 100:1770–9. doi: 10.1136/heartjnl-2014-305783
98. Tang LH, Kikkenborg Berg S, Christensen J, Lawaetz J, Doherty P, Taylor RS, et al. Patients’ preference for exercise setting and its influence on the health benefits gained from exercise-based cardiac rehabilitation. Int J Cardiol. (2017) 232:33–9. doi: 10.1016/j.ijcard.2017.01.126
99. Dnes N, Coley B, Frisby K, Keller A, Suyom J, Tsui C, et al. “A little bit of a guidance and a little bit of group support”: a qualitative study of preferences, barriers, and facilitators to participating in community-based exercise opportunities among adults living with chronic pain. Disabil Rehabil. (2021) 43:3347–56. doi: 10.1080/09638288.2020.1742801
100. D’Ascenzi F, Anselmi F, Fiorentini C, Mannucci R, Bonifazi M, Mondillo S. The benefits of exercise in cancer patients and the criteria for exercise prescription in cardio-oncology. Eur J Prev Cardiol. (2019) 16:2047487319874900. doi: 10.1177/2047487319874900
101. Batalik L, Pepera G, Papathanassiou J, Rutkowski S, Líška D, Batalikova K, et al. Is the training intensity in phase two cardiovascular rehabilitation different in telehealth versus outpatient rehabilitation? J Clin Med. (2021) 10:4069. doi: 10.3390/jcm10184069
102. Tomioka K, Iwamoto J, Saeki K, Okamoto N. Reliability and validity of the international physical activity questionnaire (IPAQ) in elderly adults: the Fujiwara-kyo study. J Epidemiol. (2011) 21:459–65. doi: 10.2188/jea.je20110003
103. Stefani L, Klika R, Mascherini G, Mazzoni F, Lunghi A, Petri C, et al. Effects of a home-based exercise rehabilitation program for cancer survivors. J Sports Med Phys Fitness. (2019) 59:846–52. doi: 10.23736/S0022-4707.18.08908-9
104. Rutkowski S, Czech O, Wrzeciono A, Kiper P, Szczepañska-Gieracha J, Malicka I. Virtual reality as a chemotherapy support in treatment of anxiety and fatigue in patients with cancer: a systematic review and meta-analysis and future research directions. Complement Ther Med. (2021) 61:102767. doi: 10.1016/j.ctim.2021.102767
105. Sunjaya AP, Chris A, Novianti D. Efficacy, patient-doctor relationship, costs and benefits of utilizing telepsychiatry for the management of post-traumatic stress disorder (PTSD): a systematic review. Trends Psychiatry Psychother. (2020) 42:102–10. doi: 10.1590/2237-6089-2019-0024
Keywords: cardio-oncology rehabilitation, telehealth, supportive cancer care, cardiac rehabilitation, exercise, cancer survivors
Citation: Batalik L, Filakova K, Radkovcova I, Dosbaba F, Winnige P, Vlazna D, Batalikova K, Felsoci M, Stefanakis M, Liska D, Papathanasiou J, Pokorna A, Janikova A, Rutkowski S and Pepera G (2022) Cardio-Oncology Rehabilitation and Telehealth: Rationale for Future Integration in Supportive Care of Cancer Survivors. Front. Cardiovasc. Med. 9:858334. doi: 10.3389/fcvm.2022.858334
Received: 19 January 2022; Accepted: 16 March 2022;
Published: 15 April 2022.
Edited by:
Richard Cheng, University of Washington Medical Center, United StatesReviewed by:
Svetlana Zaharova, Froedtert and the Medical College of Wisconsin, United StatesHugo Martinez, Le Bonheur Children’s Hospital, United States
Copyright © 2022 Batalik, Filakova, Radkovcova, Dosbaba, Winnige, Vlazna, Batalikova, Felsoci, Stefanakis, Liska, Papathanasiou, Pokorna, Janikova, Rutkowski and Pepera. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Ladislav Batalik, batalik.ladislav@fnbrno.cz